Sentences with phrase «about embryonic stem cells»

But of course, posed this way the question does not distinguish between stem cells obtained in different ways (and indeed it is sensible to assume that those who expressed opposition in response to this question believed they were being asked about embryonic stem cells, although the survey does not allow us to know that with confidence).

For further information about embryonic stem cell research, visit the Novocell website @ www.novocell.com /.

Not exact matches

For most in the scientific community, the debate was never truly about whether adult stem cells or embryonic stem cells would be the most useful therapeutically or whether we could obtain embryonic - like stem cells without destroying embryos.

In «Stem Cells: A Political History» (November 2008), Joseph Bottum and Ryan T. Anderson make a plausible sounding case that the errors manifest in politicizing the science of embryonic stem - cell research will cause people to be more prudent in the future about mixing science with politics in geneStem Cells: A Political History» (November 2008), Joseph Bottum and Ryan T. Anderson make a plausible sounding case that the errors manifest in politicizing the science of embryonic stem - cell research will cause people to be more prudent in the future about mixing science with politics in genestem - cell research will cause people to be more prudent in the future about mixing science with politics in general.

In 2005, before a Congressional hearing in the U.S., Prof. George Q. Daley of Harvard spoke forcefully and influentially about the necessity for embryonic stem - cell research to go ahead, and dismissed suggestions that one could work instead with «induced pluripotent stem cells» («iPS», i.e. stem cells reprogrammed from some cells of a living adult).

Just before Thanksgiving, news broke about a new stem - cell technique that could produce the equivalent of embryonic stem cells (ESCs) but without using or destroying human embryos.

It made the front page of the New York Times, but don't let that dissuade you ¯ reports today about new ethical sources of embryonic - type stem cells are credible, and they are very good news.

Peter Tatchell, human rights campaigner, talked about Catholic dissent from the Pope's hardline, intolerant opposition to liberation theology, women's rights, gay equality, contraception, fertility treatment, embryonic stem cell research and the Pope's collusion with Holocaust deniers and appeasers.

«The title [Congress on Responsible Stem Cell Research] was what put me off, and I thought this isn't an open discussion at all; this is going to be all about proponents for adult stem cells, and the people working with embryonic stem cells will be the bad guys,» she sStem Cell Research] was what put me off, and I thought this isn't an open discussion at all; this is going to be all about proponents for adult stem cells, and the people working with embryonic stem cells will be the bad guys,» she sstem cells, and the people working with embryonic stem cells will be the bad guys,» she sstem cells will be the bad guys,» she says.

About The Black Family Stem Cell Institute The Black Family Stem Cell Institute is Mount Sinai's foundation for both basic and disease - oriented research on embryonic and adult stem ceStem Cell Institute The Black Family Stem Cell Institute is Mount Sinai's foundation for both basic and disease - oriented research on embryonic and adult stem ceStem Cell Institute is Mount Sinai's foundation for both basic and disease - oriented research on embryonic and adult stem cestem cells.

This set the stage for a relatively restrictive environment for embryonic (although not adult) stem cell research in the United States relative to some other countries — the National Institutes of Health currently funds between about $ 600 miilion to $ 700 million a year in stem cell research.

In addition to providing an alternative to embryonic stem cells for potential use in regenerating diseased tissues, iPS cells are being used to learn more about diseases, especially diseases driven by mutated genes.

«So this relates to embryonic stem cells and why the nation is so excited about where they come from.

«The beautiful thing,» Lanza says, «is that if you have an embryonic stem cell line that is O negative, because it's immortal you could create an unlimited amount of universal blood that would match virtually everybody, so you wouldn't have to worry about matching blood types.»

When Kaufman, Zon and colleagues looked to see what was different about these early cancer cells, they found that crestin and the other activated genes are the same ones turned on during zebrafish embryonic development — specifically, in the stem cells that give rise to the pigment cells known as melanocytes, within a structure called the neural crest.

In the past few weeks, the debate about genetic research in Germany has focused on the issue of the use of embryonic stem cells for research.

Each one, formerly doomed to be tossed away as medical waste, could be used to clone embryonic stem cells that might tell stories about common diseases and how they get started.

This finding contradicts the field's presumptions about this important gene and its role in the differentiation of embryonic stem cells.

«Though the degree to which human embryonic stem cells possess this feature is not entirely clear, by understanding how another complex organism's genome works we ultimately learn more about how our own genome works,» said Zhou.

Yesterday, the same day an appeals court questioned lawyers about the case, the government filed documents in a lower court arguing that the lawsuit brought by two researchers who oppose human embryonic stem cell (hESC) research should be thrown out.

Researchers from Turku, Finland, have discovered new information about the mechanisms which maintain gene activity in human embryonic stem cells.

Scientists have suggested that such embryonic stem cells could be used for learning about genetic diseases, testing new drugs on cells grown in the lab, or growing healthy cells for therapeutic transplantation.

But embryonic clones, the source of an endless supply of stem cells imprinted with one's personal DNA, could alter the equation in favor of the patient and augur a paradigm shift in medicine on par with the changes brought about by antibiotics and vaccines.

In their experiments, about 20 percent of embryonic stem cells lacking the microRNA exhibited expanded fate potential.

The team injected about 2000 mouse embryonic stem cells each into the brains of 25 rats who had previously had their dopamine - producing neurons damaged, which causes a characteristic tendency to move in circles.

Earlier this year, scientists at University of California, Los Angeles, and Advanced Cell Technology of Marlborough, Massachusetts, reported in The Lancet about the safe and successful use of RPE cells derived from human embryonic stem cells, rather than iPS cells, to treat a different type of AMD in a limited number of human patients.

During the next five years, KOMP2 will transform the knockout mouse embryonic stem (ES) cells into adult mice for 2,500 lines of well - characterized knockout mice strains, and IMPC will create about 2,500 additional knockout mouse strains.

Almost 40 % of those who claimed some knowledge about the research in the earlier question believed, incorrectly, that embryonic stem cells had yielded therapeutic results, compared to only 23 % of those who said they were unfamiliar with the research.

About 10 years ago, Zhang was the first in the world to grow motor neurons from human embryonic stem cells.

John Gearhart, one of the first scientists to isolate, in 1998, human embryonic stem cells, also downplayed the therapeutic value of human cloning, saying «the more we learn about reprogramming, the more I think IPS will be the one of choice.»

Anger about prospects for human embryonic stem - cell research might similarly attenuate if practical applications emerge.

About four days after fertilization, that ball has developed into a blastocyst, and many of the cells within it are embryonic stem cells.

I pray for the day when James A. Thomson and others in favor of human embryonic stem cell research think about it enough to be totally uncomfortable.

April 2011 - European Court of Justice patenting case Stem cell scientists have raised serious concerns about the impact of a possible ban on patents for techniques using human embryonic stem ceStem cell scientists have raised serious concerns about the impact of a possible ban on patents for techniques using human embryonic stem cestem cells.

The company had initially submitted its request to begin human trials with its RPE cells in November 2009, but has spent the past year addressing the FDA's concerns about the safety of the embryonic stem from which the RPE cells are made.

University of Wisconsin scientist, James A. Thomson, who first derived ESCs from embryos, has said «if human embryonic stem cell research does not make you at least a little bit uncomfortable, you have not thought about it enough.»

Wicker, no political naïf, brought out the big rhetorical ammo, reminding the senators that it was Jamie Thomson, the University of Wisconsin scientist who first reported isolating the cells in 1998, who said: «If human embryonic stem cell research does not make you at least a bit uncomfortable, you have not thought about it enough.»

Furthermore, stem cells with perhaps even greater potential for therapeutic purposes are present in and retrievable from blastocytes â $» embryonic stem cells â $» and understandably, a heated debate about their use has developed.

In April of last year, the US Food and Drug Administration invited three large biotech companies - Geron, Advanced Cell Technology, and Novocell - to testify about how to safely test human embryonic stem cell (ESC) products in patieCell Technology, and Novocell - to testify about how to safely test human embryonic stem cell (ESC) products in patiecell (ESC) products in patients.

The stem cell research community hopes that as more is understood about STAP cells, they will join embryonic stem and iPS cells as another reprogramming tool for use in their collective quest to understand and treat human disease.

Such an immunological exemption could alleviate many concerns about using cells for therapy that don't exactly match the recipient's immune system - such as existing embryonic stem cell lines that are not directly derived from the recipient.

This two - volume reference integrates this exciting area of biology, combining the prerequisites for a general understanding of adult and embryonic stem cells, the tools, methods, and experimental protocols needed to study and characterize stem cells and progenitor populations, as well as a presentation by the world's experts of what is currently known about each specific organ system.

CLI President Chuck Donovan commented, «Despite the millions of dollars spent on this research, cures brought about by embryonic stem cells have continued to prove elusive, while adult stem cell research applications have exploded.»

A new study confirms a seemingly obvious assumption about human embryonic stem cell research: Countries with fewer restrictions on research outperform countries with more restrictions.

Lane believes that research in embryonic stem cells will likely be short - lived, as scientists learn what they need to know about the function of cells.

Array CGH provided a much better look at the gene content on the chromosomes of human embryonic stem cells, with a resolution about 100 times better than standard clinical methods.

Last week, a ruling by federal Judge Royce C. Lamberth left many human embryonic stem cell (hESC) researchers not only scrambling for funding and concerned about the future of their own research, but also concerned for the future of the whole field in this country.

«For a nice two decades scientists have dreamt about using human embryonic stem cells to treat diseases... that day has finally come... scientists have used human embryonic stem cells to successfully treat patients suffering from severe vision loss»

Frequently lost in the policy discussions about human embryonic stem cells research are concrete realities that will determine how quickly such research will result in treatments and cures.

And so it's really great that embryonic stem cell research was there for us, and also that most of these leads that we're talking about today came from embryonic stem cell research.